Dorsey Wright & Associates Liquidia Corp Transaction History

Dorsey Wright & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$6.63 - $9.9 $22,469 - $33,551	3,389 New	3,389 $26,000
Q2 2022 Jul 20, 2022	SELL	$3.37 - $7.55 $26,838 - $60,128	-7,964 Closed	0 $0
Q1 2022 Apr 27, 2022	BUY	$5.14 - $7.38 $40,934 - $58,774	7,964 New	7,964 $57,000
Q3 2020 Oct 28, 2020	SELL	$4.34 - $8.28 $4,600 - $8,776	-1,060 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$4.86 - $11.44 $5,151 - $12,126	1,060 New	1,060 $9,000

162

36M

1.79M

380K

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.